Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy NeoGenomics stock | $41.03

Learn how to easily invest in NeoGenomics stock.

NeoGenomics, Inc
NASDAQ: NEO - USD
DIAGNOSTICS & RESEARCH
$46.08
-$0.02 (-0.04%)

NeoGenomics, Inc is a diagnostics & research business based in the US. NeoGenomics shares (NEO) are listed on the NASDAQ and all prices are listed in US Dollars. NeoGenomics employs 1,700 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in NeoGenomics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NEO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

NeoGenomics stock price (NASDAQ: NEO)

Use our graph to track the performance of NEO stocks over time.

NeoGenomics shares at a glance

Information last updated 2021-07-29.
Latest market close$41.03
52-week range$34.18 - $61.57
50-day moving average $44.46
200-day moving average $47.43
Wall St. target price$57.27
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.04

Buy NeoGenomics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NeoGenomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NeoGenomics price performance over time

Historical closes compared with the close of $41.03 from 2021-05-28

1 week (2021-07-23) N/A
1 month (2021-07-02) -6.64%
3 months (2021-05-03) -13.78%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

Is NeoGenomics under- or over-valued?

Valuing NeoGenomics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NeoGenomics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

NeoGenomics's PEG ratio

NeoGenomics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.02. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NeoGenomics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

NeoGenomics's EBITDA

NeoGenomics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.8 million.

The EBITDA is a measure of a NeoGenomics's overall financial performance and is widely used to measure a its profitability.

NeoGenomics financials

Revenue TTM $454 million
Gross profit TTM $186.4 million
Return on assets TTM -0.81%
Return on equity TTM -1.63%
Profit margin -2.41%
Book value $7.20
Market capitalisation $5.6 billion

TTM: trailing 12 months

Shorting NeoGenomics shares

There are currently 5.9 million NeoGenomics shares held short by investors – that's known as NeoGenomics's "short interest". This figure is 1% down from 5.9 million last month.

There are a few different ways that this level of interest in shorting NeoGenomics shares can be evaluated.

NeoGenomics's "short interest ratio" (SIR)

NeoGenomics's "short interest ratio" (SIR) is the quantity of NeoGenomics shares currently shorted divided by the average quantity of NeoGenomics shares traded daily (recently around 598856.17977528). NeoGenomics's SIR currently stands at 9.79. In other words for every 100,000 NeoGenomics shares traded daily on the market, roughly 9790 shares are currently held short.

However NeoGenomics's short interest can also be evaluated against the total number of NeoGenomics shares, or, against the total number of tradable NeoGenomics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NeoGenomics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 NeoGenomics shares in existence, roughly 50 shares are currently held short) or 0.0514% of the tradable shares (for every 100,000 tradable NeoGenomics shares, roughly 51 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against NeoGenomics.

Find out more about how you can short NeoGenomics stock.

NeoGenomics share dividends

We're not expecting NeoGenomics to pay a dividend over the next 12 months.

Have NeoGenomics's shares ever split?

NeoGenomics's shares were split on a 1:100 basis on 15 April 2003. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeoGenomics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for NeoGenomics shares which in turn could have impacted NeoGenomics's share price.

NeoGenomics share price volatility

Over the last 12 months, NeoGenomics's shares have ranged in value from as little as $34.18 up to $61.57. A popular way to gauge a stock's volatility is its "beta".

NEO.US volatility(beta: 0.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeoGenomics's is 0.6844. This would suggest that NeoGenomics's shares are less volatile than average (for this exchange).

NeoGenomics overview

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited; and has collaboration with Elevation Oncology to expand genomic testing for NRG1 fusions across solid tumors. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Frequently asked questions

What percentage of NeoGenomics is owned by insiders or institutions?
Currently 4.17% of NeoGenomics shares are held by insiders and 93.83% by institutions.
How many people work for NeoGenomics?
Latest data suggests 1,700 work at NeoGenomics.
When does the fiscal year end for NeoGenomics?
NeoGenomics's fiscal year ends in December.
Where is NeoGenomics based?
NeoGenomics's address is: 12701 Commonwealth Drive, Fort Myers, FL, United States, 33913
What is NeoGenomics's ISIN number?
NeoGenomics's international securities identification number is: US64049M2098
What is NeoGenomics's CUSIP number?
NeoGenomics's Committee on Uniform Securities Identification Procedures number is: 64049M209

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site